STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

STSA SATSUMA PHARMACEUTICALS INCORPORATED StockScouter® Report

2

StockScouter® Score

SATSUMA PHARMACEUTICALS INCORPORATED, a micro cap company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Short-term relative price momentum exhibits meaningful strength. Postive

 

Concerns

  • Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
  • Moving average analysis for STSA suggests weak price movement over the medium term. Negative
  • The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 20% done.
Low
High

Core Model Grades

F
C
N/A
F

Previous Ratings

2
4
5